The Risk of recurrence in prostate cancer
by: Fritz Frei
Prostate cancer disease
Prostate cancer - the most common form of cancer in men is Prostate cancer, the second leading cause of cancer death. The Main risk factors include age (incidence increases in men over the age of 65 years). It is more prevalent in the western world and about 10% of cases can be linked to family history. The recurrance Rate of the prostate cancer is high.
Mostly, the Prostate cancer is a continuum; progressing through localized, locally advanced, advanced and hormone-refractory stages In general it is a slow growing cancer. He is primarily under hormonal control i.e. testosterone. The choice of treatments which include watchful waiting, surgery (prostatectomy), radiotherapy, hormonal therapy and chemotherapy are dependent on the stage of disease.
1. Most important, that If detected early, using PSA determination, DRE examination and biopsies, and treated appropriately, survival rates are excellent.
2. The most critical focus for the treatment of prostate cancer is to treat those cancers where it is necessary.
3. The Decisions about the best management of prostate cancer can be very complex and depend upon the:
- Pathology of the cancer (unlike other cancers, prostate cancer often progresses very slowly)
- The impact that treatment can have on quality of life, including sexual activity
- Stage of the disease (non-metastatic (localized or locally advanced), metastatic or hormone refractory)
- Age and general health of the patients at diagnosis
- Patient’s preference for treatment
- PSA at diagnosis
4. The treatment options for prostate cancer are:
- Deferred treatment often called ‘watchful waiting’ or 'active surveillance'
- Surgery – Radical Prostatectomy
- Radiotherapy – External Beam and/or Brachytherapy
-Hormonal (endocrine) therapy – Androgen Ablation e.g. anti-androgens, medical castration (LHRHa) or surgical castration
- Palliative Therapy e.g. chemotherapy
- Investigational Therapies
Prostate Cancer Recurrence Rates ***
Prostate cancer is now detected at earlier stages due to heightened awareness and improved screening techniques. Despite definitive therapy, cancer cells may remain and can go undetected for years until they develop into metastatic disease. The risk of recurrence is high, suggesting there is a need to improve treatment approaches. Therefore, it is important to predict pathological stage and risk of disease recurrence early, so that appropriate treatment and/or monitoring can be initiated. The result's of all new treatments will bring us in the future the chance of a lower prostate recurrance.
**You can inform you about the recurrence Rates on:
This gives you an overview with a study case – and the results.
Latest Cancer News:
Six Solid Ways To Reduce Your Cancer Risk -- And That Of Your Children
We hear so much these days about cancer threats from exposure to trace amounts of pesticides and industrial chemicals in our food, water, cosmetics, sleepwear, and in playgrounds. This constant drumbeat of what invariably turn out to be miniscule or non-existent threats confuses many people, and diverts attention from what are the major known, avoidable causes of cancer and what we can do to ... Cancer patients 'not referred by GP'
Thousands of people who go on to be diagnosed with cancer were not referred to a specialist by their GP, NHS England figures suggest. Research points to potential new ways to prevent colon cancer
Preventing colon cancer could be as simple as taking a pill or adjusting your diet. That?s the suggestion in new research from New York University?s Langone Medical Center. Cancer Survivors Celebrate Their Cancerversary
The lessons and messages that cancer patients and survivors draw from a fifth anniversary. Cancer: 'Half Of Doctors Failing Patients'
Family doctors have been accused of failing cancer sufferers after new data suggested more than half are not referring patients to specialists quickly enough. Figures from around 4,000 GP practices in England show that, in many cases, only a minority of patients are fast-tracked for investigation by a specialist. In some practices, only around 10% of patients eventually diagnosed with the ... Former Texas cancer agency official indicted
A former top official of the state cancer agency has been indicted on charges accusing him of fraud in connection with the awarding of an $11 million grant. Ex-Executive Indicted in Texas Cancer Fund Scandal
Texas cancer fund ex-executive indicted for alleged role in improperly awarded $11M grant Cancer Vaccine Partnering Terms and Agreements
MUMBAI, India, December 6, 2013 /PRNewswire/ -- Bharat Book Bureau presents Cancer Vaccine Partnering Terms and Agreements. This report provides an understanding and access to the cancer vaccine partnering ... Researchers develop new method for predicting ovarian cancer survival
Scientists at Fred Hutchinson Cancer Research Center have discovered a new method for predicting ovarian cancer survival. In a new study, the researchers detailed a quick and reliable way of counting the number of cancer-fighting immune cells in the body. Cancer's game of hide-and-seek
A Ludwig Cancer Research study has uncovered an entirely novel mechanism by which glioblastoma (GBM), the most common kind of brain cancer, evades targeted therapies. Published in the current issue of the journal Science, the paper describes how GBM tumor cells essentially hide the signaling molecule targeted by such therapies, adding a layer of complexity to current models of drug resistance in ... Killing cancer like the common cold - CNN